{
    "51631154298dcd4e5100004e_010": "appear to be a",
    "51631154298dcd4e5100004e_011": "multiple myeloma",
    "51631154298dcd4e5100004e_012": "multiple myeloma",
    "51631154298dcd4e5100004e_013": "multiple myeloma",
    "51631154298dcd4e5100004e_014": "multiple myeloma",
    "51631154298dcd4e5100004e_015": "multiple myeloma",
    "51631154298dcd4e5100004e_016": "literature",
    "51631154298dcd4e5100004e_017": "multiple myeloma",
    "51631154298dcd4e5100004e_018": "near-CR, including several with anthracycline-refractory disease, and another 8 having partial responses (PRs).",
    "54cf45e7f693c3b16b00000a_001": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_002": "calsequestrin (CASQ2),",
    "54cf45e7f693c3b16b00000a_003": "calsequestrin (CASQ2),",
    "54cf45e7f693c3b16b00000a_004": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_005": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_006": "usually absent, at least",
    "54cf45e7f693c3b16b00000a_007": "usually absent, at least",
    "54cf45e7f693c3b16b00000a_008": "This balance is achieved through the concerted action",
    "54cf45e7f693c3b16b00000a_009": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_010": "calsequestrin (CASQ2),",
    "54cf45e7f693c3b16b00000a_011": "calsequestrin (CASQ2),",
    "54cf45e7f693c3b16b00000a_012": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_014": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_015": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_016": "Calsequestrin",
    "54cf45e7f693c3b16b00000a_017": "Calsequestrin",
    "52f896d62059c6d71c000046_001": "memory loss",
    "56c04412ef6e39474100001b_001": "CD38",
    "56c04412ef6e39474100001b_002": "CD38",
    "56c04412ef6e39474100001b_003": "involving",
    "56c04412ef6e39474100001b_004": "involving",
    "56c04412ef6e39474100001b_005": "IgG1\u03ba",
    "56c04412ef6e39474100001b_006": "IgG1\u03ba",
    "56c04412ef6e39474100001b_007": "multiple myeloma",
    "56c04412ef6e39474100001b_008": "multiple myeloma",
    "56c04412ef6e39474100001b_009": "CD38",
    "56c04412ef6e39474100001b_010": "CD38",
    "56c04412ef6e39474100001b_011": "involving",
    "56c04412ef6e39474100001b_012": "ali",
    "56c04412ef6e39474100001b_013": "III",
    "56c04412ef6e39474100001b_014": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_015": "MM.",
    "56c04412ef6e39474100001b_016": "s killing",
    "56c04412ef6e39474100001b_017": "s killing",
    "56c04412ef6e39474100001b_018": "s killing",
    "56c04412ef6e39474100001b_019": "s killing",
    "56c04412ef6e39474100001b_020": "involving",
    "56c04412ef6e39474100001b_021": "basic",
    "56c04412ef6e39474100001b_022": "ali",
    "56c04412ef6e39474100001b_023": "multiple myeloma",
    "56c04412ef6e39474100001b_024": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_025": "involving",
    "56c04412ef6e39474100001b_026": "basic",
    "56c04412ef6e39474100001b_027": "ali",
    "56c04412ef6e39474100001b_028": "multiple myeloma",
    "56c04412ef6e39474100001b_029": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_030": "involving",
    "56c04412ef6e39474100001b_031": "basic",
    "56c04412ef6e39474100001b_032": "ali",
    "56c04412ef6e39474100001b_033": "multiple myeloma",
    "56c04412ef6e39474100001b_034": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_035": "involving",
    "56c04412ef6e39474100001b_036": "basic",
    "56c04412ef6e39474100001b_037": "ali",
    "56c04412ef6e39474100001b_038": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_039": "involving",
    "56c04412ef6e39474100001b_040": "basic",
    "56c04412ef6e39474100001b_041": "ali",
    "56c04412ef6e39474100001b_042": "multiple myeloma",
    "56c04412ef6e39474100001b_043": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_044": "basic",
    "56c04412ef6e39474100001b_045": "multiple myeloma",
    "56c04412ef6e39474100001b_046": "MM.",
    "56c04412ef6e39474100001b_047": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_048": "MM.",
    "56c04412ef6e39474100001b_049": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_050": "s killing",
    "56c04412ef6e39474100001b_051": "CD38",
    "56c04412ef6e39474100001b_052": "s killing",
    "56c04412ef6e39474100001b_053": "multiple myeloma",
    "56c04412ef6e39474100001b_054": "s killing",
    "56c04412ef6e39474100001b_055": "ali",
    "56c04412ef6e39474100001b_056": "CD38",
    "56c04412ef6e39474100001b_057": "s killing",
    "56c04412ef6e39474100001b_058": "multiple myeloma",
    "56c04412ef6e39474100001b_059": "s killing",
    "56c04412ef6e39474100001b_060": "ali",
    "56c04412ef6e39474100001b_061": "CD38",
    "56c04412ef6e39474100001b_062": "s killing",
    "56c04412ef6e39474100001b_063": "multiple myeloma",
    "56c04412ef6e39474100001b_064": "s killing",
    "56c04412ef6e39474100001b_065": "ali",
    "56c04412ef6e39474100001b_066": "CD38",
    "56c04412ef6e39474100001b_067": "s killing",
    "56c04412ef6e39474100001b_068": "multiple myeloma",
    "56c04412ef6e39474100001b_069": "CD38",
    "56c04412ef6e39474100001b_070": "CD38",
    "56c04412ef6e39474100001b_071": "CD38",
    "56c04412ef6e39474100001b_072": "s killing",
    "56c04412ef6e39474100001b_073": "ali",
    "56c04412ef6e39474100001b_074": "CD38",
    "56c04412ef6e39474100001b_075": "s killing",
    "56c04412ef6e39474100001b_076": "multiple myeloma",
    "56c04412ef6e39474100001b_077": "s killing",
    "56c04412ef6e39474100001b_078": "ali",
    "56c04412ef6e39474100001b_079": "s killing",
    "56c04412ef6e39474100001b_080": "involving",
    "56c04412ef6e39474100001b_081": "s killing",
    "56c04412ef6e39474100001b_082": "s killing",
    "56c04412ef6e39474100001b_083": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_084": "basic",
    "56c04412ef6e39474100001b_085": "involving",
    "56c04412ef6e39474100001b_086": "MM.",
    "56c04412ef6e39474100001b_087": "basic",
    "56c04412ef6e39474100001b_088": "involving",
    "56c04412ef6e39474100001b_089": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_090": "MM.",
    "56c04412ef6e39474100001b_091": "basic",
    "56c04412ef6e39474100001b_092": "involving",
    "56c04412ef6e39474100001b_093": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_094": "MM.",
    "56c04412ef6e39474100001b_095": "basic",
    "56c04412ef6e39474100001b_096": "involving",
    "56c04412ef6e39474100001b_097": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56c04412ef6e39474100001b_098": "MM.",
    "56c04412ef6e39474100001b_099": "basic",
    "56c04412ef6e39474100001b_100": "ali",
    "56c04412ef6e39474100001b_101": "involving",
    "56c04412ef6e39474100001b_102": "multiple myeloma",
    "56c04412ef6e39474100001b_103": "CD38",
    "56c04412ef6e39474100001b_104": "CD38",
    "56c04412ef6e39474100001b_105": "IgG1\u03ba",
    "56c04412ef6e39474100001b_106": "IgG1\u03ba",
    "56c04412ef6e39474100001b_107": "IgG1\u03ba",
    "56c04412ef6e39474100001b_108": "IgG1\u03ba",
    "56c04412ef6e39474100001b_109": "IgG1\u03ba",
    "56c04412ef6e39474100001b_110": "IgG1\u03ba",
    "56c04412ef6e39474100001b_111": "IgG1\u03ba",
    "56ae6e650a360a5e4500000e_001": "s and developmental",
    "56ae6e650a360a5e4500000e_002": "s and developmental",
    "56ae6e650a360a5e4500000e_003": "s and developmental",
    "56ae6e650a360a5e4500000e_004": "s and developmental",
    "56ae6e650a360a5e4500000e_005": "s and developmental",
    "56ae6e650a360a5e4500000e_007": "s and developmental",
    "56ae6e650a360a5e4500000e_008": "s and developmental",
    "56ae6e650a360a5e4500000e_009": "s and developmental",
    "56ae6e650a360a5e4500000e_010": "s and developmental",
    "56ae6e650a360a5e4500000e_011": "s and developmental",
    "56ae6e650a360a5e4500000e_012": "s and developmental",
    "56ae6e650a360a5e4500000e_013": "s and developmental",
    "56ae6e650a360a5e4500000e_014": "s and developmental",
    "56ae6e650a360a5e4500000e_015": "s and developmental",
    "56ae6e650a360a5e4500000e_016": "s and developmental",
    "56ae6e650a360a5e4500000e_017": "s and developmental",
    "56ae6e650a360a5e4500000e_018": "s and developmental",
    "56ae6e650a360a5e4500000e_019": "s and developmental",
    "56ae6e650a360a5e4500000e_020": "s and developmental",
    "56ae6e650a360a5e4500000e_025": "s and developmental",
    "5314bd7ddae131f847000006_001": "",
    "5314bd7ddae131f847000006_002": "insulin",
    "5314bd7ddae131f847000006_003": "insulin",
    "5314bd7ddae131f847000006_004": "IN",
    "5314bd7ddae131f847000006_005": "IN",
    "5314bd7ddae131f847000006_006": "IN",
    "5314bd7ddae131f847000006_007": "IN",
    "5314bd7ddae131f847000006_008": "insulin",
    "5314bd7ddae131f847000006_009": "insulin",
    "5314bd7ddae131f847000006_010": "in",
    "5314bd7ddae131f847000006_011": "in",
    "5314bd7ddae131f847000006_012": "",
    "5314bd7ddae131f847000006_013": "",
    "5314bd7ddae131f847000006_014": "",
    "5314bd7ddae131f847000006_015": "",
    "5314bd7ddae131f847000006_016": "natal",
    "5314bd7ddae131f847000006_017": "natal",
    "5314bd7ddae131f847000006_018": "or",
    "5314bd7ddae131f847000006_019": "or",
    "5314bd7ddae131f847000006_020": "or",
    "5314bd7ddae131f847000006_021": "or",
    "55180ef46487737b43000006_001": "(DH) is an autoimmunity-driven",
    "55180ef46487737b43000006_002": "ase",
    "55180ef46487737b43000006_003": "ase",
    "55180ef46487737b43000006_004": "",
    "55180ef46487737b43000006_005": "",
    "55180ef46487737b43000006_006": "papulovesicular rash and is often associated with enteropathy. The rash resolves when the patient is placed",
    "55180ef46487737b43000006_007": "dermatitis herpetiformis",
    "55180ef46487737b43000006_008": "dermatitis herpetiformis",
    "55180ef46487737b43000006_009": "dermatitis herpetiformis",
    "55180ef46487737b43000006_010": "dermatitis herpetiformis",
    "55180ef46487737b43000006_011": "DH also the",
    "55180ef46487737b43000006_012": "Dermatitis herpetiformis",
    "55180ef46487737b43000006_013": "dermatitis herpetiformis",
    "55180ef46487737b43000006_014": "dermatitis herpetiformis",
    "55180ef46487737b43000006_015": "gnomonic immunoglobulin",
    "55180ef46487737b43000006_016": "dermatitis herpetiformis",
    "55180ef46487737b43000006_017": "Dermatitis herpetiformis",
    "55180ef46487737b43000006_018": "dermatitis herpetiformis (DH),",
    "55180ef46487737b43000006_019": "",
    "55180ef46487737b43000006_020": "dermatitis herpetiformis",
    "55180ef46487737b43000006_021": "dermatitis herpetiformis",
    "55180ef46487737b43000006_022": "dermatitis herpetiformis",
    "55180ef46487737b43000006_023": "dermatitis herpetiformis",
    "55180ef46487737b43000006_024": "dermatitis herpetiformis",
    "55180ef46487737b43000006_025": "(DH) is an autoimmunity-driven",
    "55180ef46487737b43000006_026": "ase",
    "55180ef46487737b43000006_027": "papulovesicular rash and is often associated with enteropathy. The rash resolves when the patient is placed",
    "55180ef46487737b43000006_028": "",
    "55180ef46487737b43000006_030": "papulovesicular rash and is often associated with enteropathy. The rash resolves when the patient is placed",
    "55180ef46487737b43000006_031": "Dermatitis herpetiformis",
    "55180ef46487737b43000006_032": "papulovesicular rash and is often associated with enteropathy. The rash resolves when the patient is placed",
    "55180ef46487737b43000006_033": "Dermatitis herpetiformis",
    "55180ef46487737b43000006_034": "papulovesicular rash and is often associated with enteropathy. The rash resolves when the patient is placed",
    "55180ef46487737b43000006_035": "Dermatitis herpetiformis",
    "51716e808ed59a060a00000b_001": ". The model was run under scenarios of",
    "51716e808ed59a060a00000b_002": "Ixodes ricinus",
    "5156be17d24251bc05000086_001": "major",
    "5540b9800083d1bf0e000002_001": "sequestered either in spectrin's triple-helical domains or",
    "5540b9800083d1bf0e000002_002": "antiparallel",
    "5540b9800083d1bf0e000002_003": "antiparallel",
    "5540b9800083d1bf0e000002_004": "antiparallel",
    "5540b9800083d1bf0e000002_005": "antiparallel",
    "5540b9800083d1bf0e000002_009": "antiparallel",
    "5540b9800083d1bf0e000002_010": "antiparallel",
    "5540b9800083d1bf0e000002_011": "antiparallel",
    "5540b9800083d1bf0e000002_012": "antiparallel",
    "5540b9800083d1bf0e000002_013": "antiparallel",
    "5540b9800083d1bf0e000002_014": "antiparallel",
    "5540b9800083d1bf0e000002_015": "antiparallel",
    "5540b9800083d1bf0e000002_016": "antiparallel",
    "5540b9800083d1bf0e000002_017": "antiparallel",
    "5540b9800083d1bf0e000002_018": "antiparallel",
    "5540b9800083d1bf0e000002_019": "antiparallel",
    "5540b9800083d1bf0e000002_020": "antiparallel",
    "5540b9800083d1bf0e000002_021": "antiparallel",
    "5540b9800083d1bf0e000002_022": "antiparallel",
    "5540b9800083d1bf0e000002_023": "antiparallel",
    "5540b9800083d1bf0e000002_024": "antiparallel",
    "5540b9800083d1bf0e000002_025": "antiparallel",
    "5540b9800083d1bf0e000002_026": "antiparallel",
    "5540b9800083d1bf0e000002_027": "antiparallel",
    "5540b9800083d1bf0e000002_028": "antiparallel",
    "56c1f01cef6e394741000044_001": "to",
    "56c1f01cef6e394741000044_002": "epidermal growth factor receptor",
    "56b1f4300a360a5e4500001b_001": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_002": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_011": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_012": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_013": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_014": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_015": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_016": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_017": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_018": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_019": "((47)LQVVR(51))",
    "56b1f4300a360a5e4500001b_020": "((47)LQVVR(51))",
    "5325fdf0600967d132000001_001": "artificial urethral sphincter",
    "5325fdf0600967d132000001_002": "artificial urethral sphincter",
    "5325fdf0600967d132000001_003": "bone anchored",
    "5325fdf0600967d132000001_004": "bone anchored",
    "530f900ee3eabad021000003_001": "-",
    "530f900ee3eabad021000003_002": "-",
    "530f900ee3eabad021000003_003": "",
    "530f900ee3eabad021000003_004": "coding",
    "530f900ee3eabad021000003_005": "coding",
    "530f900ee3eabad021000003_006": "and vascular systems. Morpholino-based",
    "530f900ee3eabad021000003_007": "thyroid",
    "530f900ee3eabad021000003_008": "thyroid",
    "530f900ee3eabad021000003_009": "thyroid",
    "530f900ee3eabad021000003_010": "thyroid",
    "530f900ee3eabad021000003_011": "thyroid",
    "530f900ee3eabad021000003_012": "also",
    "530f900ee3eabad021000003_013": "important for the neuronal up",
    "530f900ee3eabad021000003_014": "",
    "530f900ee3eabad021000003_015": "T8",
    "530f900ee3eabad021000003_016": "T8",
    "530f900ee3eabad021000003_017": "13",
    "530f900ee3eabad021000003_018": "large",
    "530f900ee3eabad021000003_019": "thyroid",
    "54e8c7220fc566b149000002_001": "with the tumor suppressor protein p53, indicating that S100A4",
    "54e8c7220fc566b149000002_002": "with the tumor suppressor protein p53, indicating that S100A4",
    "56bc932aac7ad1001900001c_001": "CD38",
    "56bc932aac7ad1001900001c_002": "CD38",
    "56bc932aac7ad1001900001c_003": "involving",
    "56bc932aac7ad1001900001c_004": "involving",
    "56bc932aac7ad1001900001c_005": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_006": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_007": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_008": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_009": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_010": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_011": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_012": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_013": "IgG1\u03ba",
    "56bc932aac7ad1001900001c_014": "ali",
    "56bc932aac7ad1001900001c_015": "III",
    "56bc932aac7ad1001900001c_016": "CD38",
    "56bc932aac7ad1001900001c_017": "CD38",
    "56bc932aac7ad1001900001c_018": "involving",
    "56bc932aac7ad1001900001c_019": "multiple myeloma",
    "56bc932aac7ad1001900001c_020": "multiple myeloma",
    "56bc932aac7ad1001900001c_021": "MM.",
    "56bc932aac7ad1001900001c_022": "s killing",
    "56bc932aac7ad1001900001c_023": "s killing",
    "56bc932aac7ad1001900001c_024": "s killing",
    "56bc932aac7ad1001900001c_025": "s killing",
    "56bc932aac7ad1001900001c_026": "involving",
    "56bc932aac7ad1001900001c_027": "basic",
    "56bc932aac7ad1001900001c_028": "ali",
    "56bc932aac7ad1001900001c_029": "multiple myeloma",
    "56bc932aac7ad1001900001c_030": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_031": "involving",
    "56bc932aac7ad1001900001c_032": "basic",
    "56bc932aac7ad1001900001c_033": "ali",
    "56bc932aac7ad1001900001c_034": "multiple myeloma",
    "56bc932aac7ad1001900001c_035": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_036": "involving",
    "56bc932aac7ad1001900001c_037": "basic",
    "56bc932aac7ad1001900001c_038": "ali",
    "56bc932aac7ad1001900001c_039": "multiple myeloma",
    "56bc932aac7ad1001900001c_040": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_041": "involving",
    "56bc932aac7ad1001900001c_042": "basic",
    "56bc932aac7ad1001900001c_043": "ali",
    "56bc932aac7ad1001900001c_044": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_045": "involving",
    "56bc932aac7ad1001900001c_046": "basic",
    "56bc932aac7ad1001900001c_047": "ali",
    "56bc932aac7ad1001900001c_048": "multiple myeloma",
    "56bc932aac7ad1001900001c_049": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_050": "basic",
    "56bc932aac7ad1001900001c_051": "multiple myeloma",
    "56bc932aac7ad1001900001c_052": "MM.",
    "56bc932aac7ad1001900001c_053": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_054": "MM.",
    "56bc932aac7ad1001900001c_055": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_056": "s killing",
    "56bc932aac7ad1001900001c_057": "s killing",
    "56bc932aac7ad1001900001c_058": "CD38",
    "56bc932aac7ad1001900001c_059": "s killing",
    "56bc932aac7ad1001900001c_060": "multiple myeloma",
    "56bc932aac7ad1001900001c_061": "s killing",
    "56bc932aac7ad1001900001c_062": "ali",
    "56bc932aac7ad1001900001c_063": "CD38",
    "56bc932aac7ad1001900001c_064": "s killing",
    "56bc932aac7ad1001900001c_065": "multiple myeloma",
    "56bc932aac7ad1001900001c_066": "s killing",
    "56bc932aac7ad1001900001c_067": "ali",
    "56bc932aac7ad1001900001c_068": "CD38",
    "56bc932aac7ad1001900001c_069": "s killing",
    "56bc932aac7ad1001900001c_070": "multiple myeloma",
    "56bc932aac7ad1001900001c_071": "s killing",
    "56bc932aac7ad1001900001c_072": "ali",
    "56bc932aac7ad1001900001c_073": "CD38",
    "56bc932aac7ad1001900001c_074": "s killing",
    "56bc932aac7ad1001900001c_075": "multiple myeloma",
    "56bc932aac7ad1001900001c_076": "CD38",
    "56bc932aac7ad1001900001c_077": "CD38",
    "56bc932aac7ad1001900001c_078": "CD38",
    "56bc932aac7ad1001900001c_079": "s killing",
    "56bc932aac7ad1001900001c_080": "ali",
    "56bc932aac7ad1001900001c_081": "CD38",
    "56bc932aac7ad1001900001c_082": "s killing",
    "56bc932aac7ad1001900001c_083": "multiple myeloma",
    "56bc932aac7ad1001900001c_084": "s killing",
    "56bc932aac7ad1001900001c_085": "ali",
    "56bc932aac7ad1001900001c_086": "s killing",
    "56bc932aac7ad1001900001c_087": "involving",
    "56bc932aac7ad1001900001c_088": "s killing",
    "56bc932aac7ad1001900001c_089": "basic",
    "56bc932aac7ad1001900001c_090": "involving",
    "56bc932aac7ad1001900001c_091": "MM.",
    "56bc932aac7ad1001900001c_092": "basic",
    "56bc932aac7ad1001900001c_093": "involving",
    "56bc932aac7ad1001900001c_094": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_095": "MM.",
    "56bc932aac7ad1001900001c_096": "basic",
    "56bc932aac7ad1001900001c_097": "involving",
    "56bc932aac7ad1001900001c_098": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_099": "MM.",
    "56bc932aac7ad1001900001c_100": "basic",
    "56bc932aac7ad1001900001c_101": "involving",
    "56bc932aac7ad1001900001c_102": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "56bc932aac7ad1001900001c_103": "MM.",
    "56bc932aac7ad1001900001c_104": "basic",
    "56bc932aac7ad1001900001c_105": "ali",
    "56bc932aac7ad1001900001c_106": "involving",
    "56bc932aac7ad1001900001c_107": "multiple myeloma",
    "56bc932aac7ad1001900001c_108": "CD38",
    "56bc932aac7ad1001900001c_109": "CD38",
    "56bc932aac7ad1001900001c_110": "therapeutic strategy that effectively targets specific molecules on myeloma",
    "517194ef8ed59a060a000011_001": "that Plas",
    "517194ef8ed59a060a000011_002": "Plasmodium spp",
    "517194ef8ed59a060a000011_003": "Plasmodium species",
    "53551206a0726bee57000001_001": "Ad",
    "53551206a0726bee57000001_002": "Cardiotoxicity",
    "53551206a0726bee57000001_003": "Cardiotoxicity",
    "53551206a0726bee57000001_004": "cardiotoxicity",
    "53551206a0726bee57000001_005": "cardiotoxicity. Cardiac",
    "53551206a0726bee57000001_006": "cardiotoxicity. Cardiac",
    "56ffdc1ccf1c32585100000b_001": "increased diversity in transcriptome",
    "56ffdc1ccf1c32585100000b_002": "Insulin-like growth factor-binding protein-7",
    "56ffdc1ccf1c32585100000b_003": "Insulin-like growth factor-binding protein-7",
    "56ffdc1ccf1c32585100000b_004": "Insulin-like growth factor-binding protein-7",
    "56ffdc1ccf1c32585100000b_009": "(ADARs)",
    "56ffdc1ccf1c32585100000b_011": "increased diversity in transcriptome",
    "56ffdc1ccf1c32585100000b_012": "",
    "56ffdc1ccf1c32585100000b_013": "increased diversity in transcriptome",
    "56ffdc1ccf1c32585100000b_014": "",
    "56ffdc1ccf1c32585100000b_016": "increased diversity in transcriptome",
    "56cae3eb5795f9a73e000021_001": "Crohn's",
    "5509bd6a1180f13250000002_001": "celiac disease",
    "5509bd6a1180f13250000002_002": "celiac disease",
    "5509bd6a1180f13250000002_003": "",
    "5509bd6a1180f13250000002_004": "",
    "54e0d7471388e8454a000015_001": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_002": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_003": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_004": "Anti-interleukin-17A",
    "54e0d7471388e8454a000015_005": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_006": "interleukin-17A",
    "54e0d7471388e8454a000015_007": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_008": "anti-interleukin-17A",
    "54e0d7471388e8454a000015_009": "interleukin-17A",
    "54f9c40ddd3fc62544000001_001": "calcineurin",
    "54f9c40ddd3fc62544000001_002": "Calcineurin",
    "54f9c40ddd3fc62544000001_003": "Calcineurin",
    "54f9c40ddd3fc62544000001_004": "Calcineurin",
    "54f9c40ddd3fc62544000001_005": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_006": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_007": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_008": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_009": "calcineurin",
    "54f9c40ddd3fc62544000001_010": "calcineurin",
    "54f9c40ddd3fc62544000001_011": "",
    "54f9c40ddd3fc62544000001_012": "calcineurin",
    "54f9c40ddd3fc62544000001_013": "Calcineurin",
    "54f9c40ddd3fc62544000001_014": "calcineurin",
    "54f9c40ddd3fc62544000001_015": "Calcineurin",
    "54f9c40ddd3fc62544000001_016": "Calcineurin",
    "54f9c40ddd3fc62544000001_017": "Calcineurin",
    "54f9c40ddd3fc62544000001_018": "calcineurin",
    "54f9c40ddd3fc62544000001_019": "calcineurin",
    "54f9c40ddd3fc62544000001_020": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_021": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_022": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_023": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_024": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_025": "phosphatase 2B",
    "54f9c40ddd3fc62544000001_027": "calcineurin",
    "532ff917d6d3ac6a34000038_001": "histone modification mark, histone",
    "532ff917d6d3ac6a34000038_002": "addition, the deletion of",
    "532ff917d6d3ac6a34000038_003": "genes",
    "532ff917d6d3ac6a34000038_004": "genes. However, the position of",
    "569e7721ceceede94d000001_003": "the Mammalian Genomes 4",
    "56a24dfffe92d6fd19000002_011": "troph",
    "5324ce779b2d7acc7e00001e_001": "effects of prega",
    "5324ce779b2d7acc7e00001e_002": "effects of prega",
    "56c3184050c68dd416000003_001": "4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.5",
    "56c3184050c68dd416000003_002": "calcium",
    "56c3184050c68dd416000003_003": "4.55 +/- 0.56 mg twice daily; n = 11) or isradipine (7.5",
    "56c3184050c68dd416000003_004": "angiotensin-converting enzyme",
    "56c3184050c68dd416000003_005": "Antihypertensive Long-term Therapy with Isradipine/Improvement",
    "56c3184050c68dd416000003_006": "arterial",
    "56c3184050c68dd416000003_007": "and efficacy in elderly patients. Dosage step-up",
    "56c3184050c68dd416000003_008": "atenolol. After a three-week placebo treatment period, patients received either isradipine (2.5,",
    "56c3184050c68dd416000003_012": "fibroblasts",
    "530cf4c54a5037880c000008_001": "tyrosine kinase (BTK) shows constitutive activity in CLL and is",
    "530cf4c54a5037880c000008_002": "tyrosine kinase (BTK) shows constitutive activity in CLL and is",
    "530cf4c54a5037880c000008_003": "tyrosine kinase (BTK) shows constitutive activity in CLL and is",
    "530cf4c54a5037880c000008_004": "tyrosine kinase (BTK) shows constitutive activity in CLL and is",
    "530cf4c54a5037880c000008_005": "C",
    "530cf4c54a5037880c000008_006": "Ibrutinib",
    "530cf4c54a5037880c000008_007": "in CLL with confirmed pathogenic significance. This clinical trial was registered at clinicaltrials.gov;",
    "530cf4c54a5037880c000008_008": "ibrutinib",
    "530cf4c54a5037880c000008_009": "ibrutinib",
    "530cf4c54a5037880c000008_010": "",
    "530cf4c54a5037880c000008_011": "ted",
    "530cf4c54a5037880c000008_012": "regimens. Ibrutinib,",
    "530cf4c54a5037880c000008_013": "regimens. Ibrutinib,",
    "530cf4c54a5037880c000008_014": "BCR",
    "530cf4c54a5037880c000008_015": "Ibrutinib",
    "530cf4c54a5037880c000008_016": "s tyrosine kinase (",
    "530cf4c54a5037880c000008_017": "(Ibrutinib,",
    "54f2210164850a5854000001_001": "of a bis-disulfide analogue of the Cys*-X-Cys* hepcidin",
    "55242d512c8b63434a000006_001": "5-HT2ARs",
    "55242d512c8b63434a000006_002": "5-HT2ARs",
    "55242d512c8b63434a000006_003": "5-HT2ARs",
    "55242d512c8b63434a000006_004": "(5-HT2A",
    "55242d512c8b63434a000006_005": "(5-HT2A",
    "55242d512c8b63434a000006_006": "5-HT2A receptor binding (5-HT2AR)",
    "55242d512c8b63434a000006_007": "5-HT2A receptor binding (5-HT2AR)",
    "55242d512c8b63434a000006_008": "5-HT2A receptor",
    "55242d512c8b63434a000006_009": "5-HT2A receptor",
    "55242d512c8b63434a000006_010": "5-HT2A receptor",
    "55242d512c8b63434a000006_011": "5-HT2A receptor",
    "55242d512c8b63434a000006_012": "5-HT2A receptor",
    "55242d512c8b63434a000006_013": "5-HT2A receptor",
    "55242d512c8b63434a000006_014": "5-HT2A",
    "55242d512c8b63434a000006_015": "5-HT2A",
    "55242d512c8b63434a000006_016": "5-HT2A",
    "55242d512c8b63434a000006_017": "5-HT1A",
    "55242d512c8b63434a000006_018": "5-HT2A receptor.",
    "55242d512c8b63434a000006_019": "5-HT2A",
    "55242d512c8b63434a000006_020": "take correlates negatively",
    "55242d512c8b63434a000006_021": "5-HT2A",
    "55242d512c8b63434a000006_022": "5-HT2A receptor.",
    "55242d512c8b63434a000006_023": "5-HT2A receptor.",
    "55242d512c8b63434a000006_024": "5-HT2A",
    "55242d512c8b63434a000006_025": "take correlates negatively",
    "55242d512c8b63434a000006_026": "5-HT2A",
    "55242d512c8b63434a000006_027": "5-HT2A receptor.",
    "55242d512c8b63434a000006_028": "5-HT2A receptor.",
    "55242d512c8b63434a000006_029": "5-HT2A",
    "55242d512c8b63434a000006_030": "take correlates negatively",
    "55242d512c8b63434a000006_031": "5-HT2A",
    "55242d512c8b63434a000006_032": "5-HT2A receptor.",
    "55242d512c8b63434a000006_033": "5-HT2A receptor.",
    "55242d512c8b63434a000006_034": "5-HT2A",
    "55242d512c8b63434a000006_035": "take correlates negatively",
    "55242d512c8b63434a000006_036": "5-HT2A",
    "55242d512c8b63434a000006_037": "5-HT2A receptor.",
    "55242d512c8b63434a000006_038": "5-HT2A",
    "55242d512c8b63434a000006_039": "5-HT2A",
    "55242d512c8b63434a000006_040": "5-HT2A",
    "55242d512c8b63434a000006_041": "5-HT2A receptor.",
    "55242d512c8b63434a000006_042": "5-HT2A receptor.",
    "55242d512c8b63434a000006_043": "5-HT2A receptor.",
    "55242d512c8b63434a000006_044": "5-HT2ARs",
    "55242d512c8b63434a000006_045": "5-HT2ARs",
    "55242d512c8b63434a000006_046": "5-HT2ARs",
    "55242d512c8b63434a000006_047": "take correlates negatively",
    "55242d512c8b63434a000006_048": "take correlates negatively",
    "55242d512c8b63434a000006_049": "5-HT2A",
    "55242d512c8b63434a000006_050": "5-HT2A",
    "55242d512c8b63434a000006_051": "(5-HT2A",
    "55242d512c8b63434a000006_052": "5-HT2aR",
    "55242d512c8b63434a000006_053": "(5-HT2A",
    "55242d512c8b63434a000006_054": "5-HT2A",
    "55242d512c8b63434a000006_055": "5-HT2ARs",
    "55242d512c8b63434a000006_056": "5-HT2ARs",
    "55242d512c8b63434a000006_057": "5-HT2A",
    "55242d512c8b63434a000006_058": "5-HT2A receptor.",
    "55242d512c8b63434a000006_059": "5-HT2A receptor.",
    "55242d512c8b63434a000006_060": "5-HT2A",
    "55242d512c8b63434a000006_061": "5-HT2ARs",
    "55242d512c8b63434a000006_062": "5-HT2ARs",
    "55242d512c8b63434a000006_063": "5-HT2A receptor.",
    "55242d512c8b63434a000006_064": "5-HT2A",
    "55242d512c8b63434a000006_065": "5-HT2A receptor.",
    "55242d512c8b63434a000006_066": "5-HT2A",
    "55242d512c8b63434a000006_067": "5-HT2A",
    "55242d512c8b63434a000006_068": "5-HT2ARs",
    "55242d512c8b63434a000006_069": "5-HT2ARs",
    "55242d512c8b63434a000006_070": "5-HT2A receptor.",
    "55242d512c8b63434a000006_071": "5-HT2A receptor.",
    "55242d512c8b63434a000006_072": "5-HT2A",
    "55242d512c8b63434a000006_073": "5-HT2A",
    "55242d512c8b63434a000006_074": "5-HT2ARs",
    "55242d512c8b63434a000006_075": "5-HT2ARs",
    "55242d512c8b63434a000006_076": "5-HT2A receptor.",
    "55242d512c8b63434a000006_077": "5-HT2A receptor.",
    "55242d512c8b63434a000006_078": "5-HT2A",
    "55242d512c8b63434a000006_079": "5-HT2A",
    "55242d512c8b63434a000006_080": "5-HT2ARs",
    "55242d512c8b63434a000006_081": "5-HT2ARs",
    "55242d512c8b63434a000006_082": "5-HT2A",
    "55242d512c8b63434a000006_083": "5-HT2A receptor.",
    "55242d512c8b63434a000006_084": "5-HT2A receptor.",
    "55242d512c8b63434a000006_085": "5-HT2A",
    "55242d512c8b63434a000006_086": "take correlates negatively",
    "56f6c11109dd18d46b00000e_001": "activity on T-cell",
    "56f6c11109dd18d46b00000e_002": "CsA",
    "56f6c11109dd18d46b00000e_003": "CsA",
    "536e46f27d100faa09000012_001": "HEXA",
    "536e46f27d100faa09000012_002": "in exon 8 (S279P).",
    "536e46f27d100faa09000012_003": "in exon 8 (S279P).",
    "536e46f27d100faa09000012_004": "HEXA",
    "536e46f27d100faa09000012_005": ". A relatively high frequency",
    "536e46f27d100faa09000012_006": "HEXA",
    "536e46f27d100faa09000012_007": "we",
    "536e46f27d100faa09000012_008": "we",
    "536e46f27d100faa09000012_009": "HEXA",
    "536e46f27d100faa09000012_010": "in exon 8 (S279P).",
    "536e46f27d100faa09000012_011": "HEXA",
    "536e46f27d100faa09000012_012": "HEXA",
    "536e46f27d100faa09000012_013": "HEXA",
    "536e46f27d100faa09000012_016": "in exon 8 (S279P).",
    "53148a07dae131f847000002_001": "roid gland",
    "53148a07dae131f847000002_002": "normal endolymph composition and the maintenance of",
    "53148a07dae131f847000002_003": "normal endolymph composition and the maintenance of",
    "53148a07dae131f847000002_004": "",
    "53148a07dae131f847000002_005": "thyroid",
    "53148a07dae131f847000002_006": "thyroid",
    "53148a07dae131f847000002_007": "thyroid",
    "53148a07dae131f847000002_008": "thyroid",
    "53148a07dae131f847000002_009": "rin can mediate iod",
    "53148a07dae131f847000002_010": "are essential",
    "53148a07dae131f847000002_011": "are essential",
    "53148a07dae131f847000002_012": "which encodes pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the",
    "53148a07dae131f847000002_013": "which encodes pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the",
    "53148a07dae131f847000002_014": "which encodes pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the",
    "53148a07dae131f847000002_015": "thyroid",
    "53148a07dae131f847000002_016": "thyroid",
    "53148a07dae131f847000002_017": "thyroid",
    "53148a07dae131f847000002_018": "thyroid",
    "53148a07dae131f847000002_019": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_020": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_021": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_022": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_023": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_024": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_025": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
    "53148a07dae131f847000002_026": "age",
    "53148a07dae131f847000002_027": "age",
    "53148a07dae131f847000002_028": "",
    "53148a07dae131f847000002_029": "",
    "53148a07dae131f847000002_030": "thyroid",
    "53148a07dae131f847000002_031": "thyroid",
    "53148a07dae131f847000002_032": ".",
    "53148a07dae131f847000002_033": "thyroid",
    "53148a07dae131f847000002_034": "thyroid",
    "53148a07dae131f847000002_035": "thyroid",
    "53148a07dae131f847000002_036": "ification defects",
    "53148a07dae131f847000002_037": "ification defects",
    "53148a07dae131f847000002_038": "thyroid",
    "53148a07dae131f847000002_039": "thyroid",
    "53148a07dae131f847000002_040": "thyroid",
    "53148a07dae131f847000002_041": "thyroid",
    "53148a07dae131f847000002_042": "thyroid",
    "53148a07dae131f847000002_043": "hypothyroid",
    "53148a07dae131f847000002_044": "hypothyroid",
    "53148a07dae131f847000002_045": "thyroid",
    "53148a07dae131f847000002_046": "the thy",
    "53148a07dae131f847000002_047": "thyroid",
    "53148a07dae131f847000002_048": "thyroid",
    "53148a07dae131f847000002_049": "gene",
    "53148a07dae131f847000002_050": "roid gland",
    "53148a07dae131f847000002_051": "thyroid",
    "53148a07dae131f847000002_052": "thyroid",
    "52eea4dcc8da89891000000c_001": "autosomal recessive",
    "52eea4dcc8da89891000000c_002": "the protein",
    "52eea4dcc8da89891000000c_003": "dominant or recessive",
    "56c85ed65795f9a73e000012_002": "molecule",
    "56c85ed65795f9a73e000012_004": "molecule",
    "56c85ed65795f9a73e000012_005": "Tregs which regulate anti-tumor/leukaemia",
    "56c85ed65795f9a73e000012_007": "molecule",
    "534427f8aeec6fbd07000009_001": "non-synonymous",
    "534427f8aeec6fbd07000009_002": "non-synonymous",
    "534427f8aeec6fbd07000009_003": "non-synonymous",
    "534427f8aeec6fbd07000009_004": "be determined across all genes or in a gene-specific manner. This choice introduces an",
    "533abc76d6d3ac6a34000064_001": "B-cell-specific Moloney",
    "533abc76d6d3ac6a34000064_002": "p16INK4a",
    "533abc76d6d3ac6a34000064_003": "regulated",
    "533abc76d6d3ac6a34000064_004": "of",
    "533abc76d6d3ac6a34000064_005": "p16Ink4a and inhibiting p53",
    "533abc76d6d3ac6a34000064_006": "reverse transcription-PCR,",
    "571f5c150fd6f91b68000009_001": "iron",
    "571f5c150fd6f91b68000009_002": "ataxia is a severe neurodegenerative disease caused by the decreased expression of frataxin, a mitochondrial protein that",
    "571f5c150fd6f91b68000009_003": "FXN",
    "571f5c150fd6f91b68000009_004": "frataxin",
    "571f5c150fd6f91b68000009_005": "frataxin",
    "571f5c150fd6f91b68000009_006": "mitochondrial",
    "571f5c150fd6f91b68000009_007": "(FRDA),",
    "571f5c150fd6f91b68000009_008": "ataxia (FRDA), the most common form of recessive hereditary ataxia.",
    "571f5c150fd6f91b68000009_009": "mitochondria",
    "571f5c150fd6f91b68000009_010": "frataxin",
    "571f5c150fd6f91b68000009_011": "mitochondrial",
    "571f5c150fd6f91b68000009_012": "frataxin",
    "571f5c150fd6f91b68000009_013": "mitochondria",
    "571f5c150fd6f91b68000009_014": "plays a",
    "571f5c150fd6f91b68000009_015": "M",
    "571f5c150fd6f91b68000009_016": "iron",
    "571f5c150fd6f91b68000009_017": "iron",
    "571f5c150fd6f91b68000009_018": "nuclearencoded protein frataxin is essential for the mitochondrial biosynthesis of ISCs. Frataxin",
    "571f5c150fd6f91b68000009_019": "frataxin",
    "571f5c150fd6f91b68000009_021": "frataxin",
    "571f5c150fd6f91b68000009_022": "lacking",
    "571f5c150fd6f91b68000009_023": "frataxin",
    "571f5c150fd6f91b68000009_024": "lacking",
    "571f5c150fd6f91b68000009_025": "frataxin",
    "571f5c150fd6f91b68000009_026": "lacking",
    "571f5c150fd6f91b68000009_027": "",
    "51387022bee46bd34c000002_001": "development",
    "51387022bee46bd34c000002_002": "development",
    "51387022bee46bd34c000002_003": "stage-specific",
    "51387022bee46bd34c000002_004": "Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development. Researchers have",
    "51387022bee46bd34c000002_005": "expression they control. On the loci of two developmental transcription factor genes, SOX3",
    "51387022bee46bd34c000002_006": "expression they control. On the loci of two developmental transcription factor genes, SOX3",
    "51387022bee46bd34c000002_007": "Possible involvement",
    "51387022bee46bd34c000002_008": "",
    "51387022bee46bd34c000002_009": "regulatory",
    "51387022bee46bd34c000002_010": "have",
    "51387022bee46bd34c000002_011": "have",
    "51387022bee46bd34c000002_012": "ine 27",
    "51387022bee46bd34c000002_013": "ine 27",
    "56df03c751531f7e3300000a_001": "epi",
    "56df03c751531f7e3300000a_002": "methyltransferase complex,",
    "533be71dfd9a95ea0d000009_001": "(VTA)",
    "533be71dfd9a95ea0d000009_002": "overexpressed in prostate",
    "533be71dfd9a95ea0d000009_003": "(H3K4me3).",
    "533be71dfd9a95ea0d000009_004": "H3K4",
    "533be71dfd9a95ea0d000009_005": "(H3K4)",
    "533be71dfd9a95ea0d000009_006": "essential for",
    "533be71dfd9a95ea0d000009_007": "H3 (H3K4).",
    "533be71dfd9a95ea0d000009_008": "methyltransferase (H3K4me3) complex and that HIV-1 Tat",
    "533be71dfd9a95ea0d000009_009": "not on the",
    "533be71dfd9a95ea0d000009_010": "not on the",
    "533be71dfd9a95ea0d000009_011": "a highly variable but essential",
    "533be71dfd9a95ea0d000009_012": "yet in mammal",
    "533be71dfd9a95ea0d000009_013": "yet in mammal",
    "533be71dfd9a95ea0d000009_014": "be important",
    "533be71dfd9a95ea0d000009_015": "H3K4",
    "533be71dfd9a95ea0d000009_016": "",
    "533be71dfd9a95ea0d000009_017": "(H3K4).",
    "56c8274f5795f9a73e00000d_001": "amyotrophic lateral sclerosis (ALS),",
    "56c8274f5795f9a73e00000d_002": "POLDIP3",
    "56c8274f5795f9a73e00000d_003": "POLDIP3",
    "56c8274f5795f9a73e00000d_004": "SOD1",
    "56c8274f5795f9a73e00000d_005": "spasticity is traditionally thought to be the result of degeneration of the upper motor neurons in the cerebral cortex",
    "5545e65bd355485447000001_001": "s accumulate in degenerating neurons of most individuals with",
    "531464a6e3eabad021000014_001": "",
    "531464a6e3eabad021000014_002": "associated with suscept",
    "531464a6e3eabad021000014_003": "associated with suscept",
    "531464a6e3eabad021000014_004": "",
    "531464a6e3eabad021000014_005": "",
    "531464a6e3eabad021000014_006": "XK",
    "531464a6e3eabad021000014_007": "XK",
    "531464a6e3eabad021000014_008": "XK",
    "531464a6e3eabad021000014_009": "XK",
    "531464a6e3eabad021000014_010": "XK",
    "531464a6e3eabad021000014_011": "XK",
    "531464a6e3eabad021000014_012": "XK",
    "531464a6e3eabad021000014_013": "XK",
    "531464a6e3eabad021000014_014": "",
    "531464a6e3eabad021000014_015": "the differential diagnosis of Huntington",
    "531464a6e3eabad021000014_016": "(XK)",
    "531464a6e3eabad021000014_017": "(XK)",
    "531464a6e3eabad021000014_018": "(XK)",
    "531464a6e3eabad021000014_019": "(XK)",
    "531464a6e3eabad021000014_020": "(XK)",
    "531464a6e3eabad021000014_021": "(XK)",
    "531464a6e3eabad021000014_022": "XK",
    "531464a6e3eabad021000014_023": "XK",
    "531464a6e3eabad021000014_024": "XK",
    "531464a6e3eabad021000014_025": "XK",
    "531464a6e3eabad021000014_026": "XK",
    "531464a6e3eabad021000014_027": "t",
    "531464a6e3eabad021000014_028": "",
    "531464a6e3eabad021000014_029": "",
    "531464a6e3eabad021000014_030": "",
    "531464a6e3eabad021000014_031": "is typically",
    "531464a6e3eabad021000014_032": "is typically",
    "531464a6e3eabad021000014_033": "is typically",
    "531464a6e3eabad021000014_034": "is typically",
    "531464a6e3eabad021000014_035": "is typically",
    "531464a6e3eabad021000014_036": "XK",
    "531464a6e3eabad021000014_037": "XK",
    "531464a6e3eabad021000014_038": "XK",
    "531464a6e3eabad021000014_039": "XK",
    "531464a6e3eabad021000014_040": "XK",
    "531464a6e3eabad021000014_041": "XK",
    "531464a6e3eabad021000014_042": "XK",
    "531464a6e3eabad021000014_043": "osis",
    "531464a6e3eabad021000014_044": "system",
    "531464a6e3eabad021000014_045": "system",
    "531464a6e3eabad021000014_046": "The movement disorder commonly develops in the fifth decade and is progressive. It affects",
    "531464a6e3eabad021000014_047": "",
    "531464a6e3eabad021000014_048": "",
    "531464a6e3eabad021000014_049": ", we present an immunohistochemical study in",
    "531464a6e3eabad021000014_050": ", we present an immunohistochemical study in",
    "531464a6e3eabad021000014_051": ", we present an immunohistochemical study in",
    "531464a6e3eabad021000014_052": ", we present an immunohistochemical study in",
    "531464a6e3eabad021000014_053": "antigen, weak expression of",
    "531464a6e3eabad021000014_054": "antigen, weak expression of",
    "531464a6e3eabad021000014_055": "antigen, weak expression of",
    "531464a6e3eabad021000014_056": "XK protein on RBC membranes by Western immunoblotting, by sequencing the XK",
    "531464a6e3eabad021000014_057": "",
    "531464a6e3eabad021000014_058": "DXS",
    "531464a6e3eabad021000014_059": "",
    "531464a6e3eabad021000014_060": "",
    "531464a6e3eabad021000014_061": "",
    "531464a6e3eabad021000014_062": "ide sequence analysis",
    "531464a6e3eabad021000014_063": "ide sequence analysis",
    "531464a6e3eabad021000014_064": "for Duchenne muscular dystroph",
    "531464a6e3eabad021000014_065": "",
    "53124bdae3eabad02100000b_001": "(mTOR),",
    "53124bdae3eabad02100000b_002": "(mTOR)",
    "53124bdae3eabad02100000b_003": "growth, stem cell proliferation and disease relapse. Rapamycin",
    "53124bdae3eabad02100000b_004": "rap",
    "53124bdae3eabad02100000b_005": "(mTOR)",
    "53124bdae3eabad02100000b_006": "(mTOR)",
    "53124bdae3eabad02100000b_007": "is warrant",
    "53124bdae3eabad02100000b_008": "were",
    "53124bdae3eabad02100000b_009": "kinase",
    "53124bdae3eabad02100000b_010": "(HR(+)) breast cancer.",
    "53124bdae3eabad02100000b_011": "(mTOR),",
    "54fc91e96ad7dcbc12000001_001": "Alzheimer's disease",
    "54fc91e96ad7dcbc12000001_002": "Alzheimer's disease",
    "54fc91e96ad7dcbc12000001_003": "ineffective. Herbal",
    "54fc91e96ad7dcbc12000001_004": "amyloid-beta",
    "54fc91e96ad7dcbc12000001_005": "amyloid-beta",
    "54fc91e96ad7dcbc12000001_006": "Alzheimer's disease",
    "53318685d6d3ac6a3400003d_001": "autosomal dominant",
    "53318685d6d3ac6a3400003d_002": "autosomal dominant",
    "53318685d6d3ac6a3400003d_003": "autosomal dominant",
    "53318685d6d3ac6a3400003d_004": "rare bone dysplasia characterised by short stature, short hands and feet, normal intelligence,",
    "511a3573df1ebcce7d000018_001": "diverse physiological functions. Recently, growing evidence indicates that",
    "511a3573df1ebcce7d000018_002": "15",
    "511a3573df1ebcce7d000018_003": "15",
    "511a3573df1ebcce7d000018_004": "been implicated in pathophysiology of brain",
    "511a3573df1ebcce7d000018_005": "(hK1-hK15",
    "511a3573df1ebcce7d000018_006": "(hK1-hK15",
    "511a3573df1ebcce7d000018_007": "of",
    "511a3573df1ebcce7d000018_008": "15",
    "511a3573df1ebcce7d000018_009": "15",
    "511a3573df1ebcce7d000018_010": "15",
    "511a3573df1ebcce7d000018_011": "15",
    "511a3573df1ebcce7d000018_012": ".",
    "511a3573df1ebcce7d000018_013": "markers",
    "511a3573df1ebcce7d000018_014": "human",
    "511a3573df1ebcce7d000018_015": "that kallikreins",
    "56c865d25795f9a73e000016_001": "GKT136901, a specific inhibitor",
    "56c865d25795f9a73e000016_002": "(ET-1)",
    "56c865d25795f9a73e000016_003": "GKT136901, a specific inhibitor",
    "550e828c71445a662f000002_001": "IL-1\u03b2",
    "550e828c71445a662f000002_002": "IL-1\u03b2",
    "550e828c71445a662f000002_003": "IL-1\u03b2",
    "550e828c71445a662f000002_004": "IL-1\u03b2",
    "550e828c71445a662f000002_005": "IL-1\u03b2",
    "550e828c71445a662f000002_006": "IL-1\u03b2",
    "550e828c71445a662f000002_007": "IL-1\u03b2",
    "550e828c71445a662f000002_008": "IL-1\u03b2",
    "550e828c71445a662f000002_009": "IL-1\u03b2",
    "550e828c71445a662f000002_010": "IL-1\u03b2",
    "550e828c71445a662f000002_011": "IL-1\u03b2",
    "550e828c71445a662f000002_012": "IL-1\u03b2",
    "550e828c71445a662f000002_013": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_014": "potential treatment of type 1",
    "550e828c71445a662f000002_015": "potential treatment of type 1",
    "550e828c71445a662f000002_016": "potential treatment of type 1",
    "550e828c71445a662f000002_017": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_018": "IL-1\u03b2",
    "550e828c71445a662f000002_019": "IL-1\u03b2",
    "550e828c71445a662f000002_020": "IL-1\u03b2",
    "550e828c71445a662f000002_021": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_022": "IL-1\u03b2",
    "550e828c71445a662f000002_023": "IL-1\u03b2",
    "550e828c71445a662f000002_024": "IL-1\u03b2",
    "550e828c71445a662f000002_025": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_026": "IL-1\u03b2",
    "550e828c71445a662f000002_027": "IL-1\u03b2",
    "550e828c71445a662f000002_028": "IL-1\u03b2",
    "550e828c71445a662f000002_029": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_030": "IL-1\u03b2",
    "550e828c71445a662f000002_031": "IL-1\u03b2",
    "550e828c71445a662f000002_032": "IL-1\u03b2",
    "550e828c71445a662f000002_033": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_034": "IL-1\u03b2",
    "550e828c71445a662f000002_035": "IL-1\u03b2",
    "550e828c71445a662f000002_036": "IL-1\u03b2",
    "550e828c71445a662f000002_037": "IL-1\u03b2",
    "550e828c71445a662f000002_038": "IL-1\u03b2",
    "550e828c71445a662f000002_039": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_040": "IL-1\u03b2",
    "550e828c71445a662f000002_041": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_042": "IL-1\u03b2",
    "550e828c71445a662f000002_043": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_044": "IL-1\u03b2",
    "550e828c71445a662f000002_045": "anti-IL-1\u03b2",
    "550e828c71445a662f000002_046": "IL-1\u03b2",
    "550e828c71445a662f000002_047": "anti-IL-1\u03b2",
    "54f608f85f206a0c06000007_001": "al corepressor that directly interacts",
    "56c048acef6e39474100001c_001": "telomerase",
    "56c048acef6e39474100001c_002": "telomerase",
    "56c048acef6e39474100001c_003": "telomerase",
    "56c048acef6e39474100001c_004": "GRN163L",
    "56c048acef6e39474100001c_005": "GRN163L",
    "56c048acef6e39474100001c_006": "omer",
    "56c048acef6e39474100001c_007": "omer",
    "56c048acef6e39474100001c_008": "omer",
    "56c048acef6e39474100001c_009": "Imetelstat",
    "56c048acef6e39474100001c_010": "Imetelstat",
    "56c048acef6e39474100001c_011": "Imetelstat",
    "56c048acef6e39474100001c_012": "telomerase",
    "56c048acef6e39474100001c_013": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_014": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_015": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_016": "telomerase",
    "56c048acef6e39474100001c_017": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_018": "imetelstat",
    "56c048acef6e39474100001c_019": "telomerase",
    "56c048acef6e39474100001c_020": "omer",
    "56c048acef6e39474100001c_021": "telomerase",
    "56c048acef6e39474100001c_022": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_023": "imetelstat",
    "56c048acef6e39474100001c_024": "telomerase",
    "56c048acef6e39474100001c_025": "omer",
    "56c048acef6e39474100001c_026": "imetelstat",
    "56c048acef6e39474100001c_027": "imetelstat",
    "56c048acef6e39474100001c_028": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_029": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_030": "telomerase",
    "56c048acef6e39474100001c_031": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_032": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_033": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_034": "telomerase",
    "56c048acef6e39474100001c_035": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_036": "Imetelstat",
    "56c048acef6e39474100001c_037": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_038": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_039": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_040": "telomerase",
    "56c048acef6e39474100001c_041": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_042": "telomerase",
    "56c048acef6e39474100001c_043": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_044": "Imetelstat",
    "56c048acef6e39474100001c_045": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_046": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_047": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_048": "telomerase",
    "56c048acef6e39474100001c_049": "Imetelstat",
    "56c048acef6e39474100001c_050": "imetelstat",
    "56c048acef6e39474100001c_051": "imetelstat",
    "56c048acef6e39474100001c_052": "drug candidate for treatment of es",
    "56c048acef6e39474100001c_053": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_054": "telomerase",
    "56c048acef6e39474100001c_055": "telomerase",
    "56c048acef6e39474100001c_056": "telomerase",
    "56c048acef6e39474100001c_057": "imetelstat",
    "56c048acef6e39474100001c_058": "imetelstat",
    "56c048acef6e39474100001c_059": "imetelstat (GRN163L),",
    "56c048acef6e39474100001c_060": "telomerase",
    "56c048acef6e39474100001c_061": "imetelstat (GRN163L),",
    "512d0e635274a5fb07000005_001": "anti",
    "512d0e635274a5fb07000005_002": "",
    "512d0e635274a5fb07000005_003": "etanercept"
}
